CELL
PhenomeX Inc. Common Stock
CELL
CELL
Delisted
CELL was delisted on the 29th of September, 2023.
112 hedge funds and large institutions have $138M invested in PhenomeX Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less capital invested
Capital invested by funds: $244M → $138M (-$106M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
112
Holding in Top 10
1
Calls
$101K
Puts
$69K
Top Buyers
| 1 | +$3.65M | |
| 2 | +$2.23M | |
| 3 | +$1.86M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$698K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$698K |
Top Sellers
| 1 | -$8.45M | |
| 2 | -$2.14M | |
| 3 | -$949K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$948K |
| 5 |
DnB Asset Management
Oslo,
Norway
|
-$880K |